![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 49829](https://www.bertin-technologies.com/wp-content/uploads/2022/08/Group-56.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 49831](https://www.bertin-technologies.com/wp-content/uploads/2022/08/Group-57.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 51209](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-cbrn-1.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 49833](https://www.bertin-technologies.com/wp-content/uploads/2022/08/Group-58.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 49835](https://www.bertin-technologies.com/wp-content/uploads/2022/08/Group-59.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 51211](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-space-big-science-1.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 51200](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-optronics.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 51204](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-optomechanical.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 51202](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-photonics.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 51212](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-application-center.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 51214](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-distributor-map.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 51216](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-register-1.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 51218](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-media.svg)
![[PRECELLYS] Lipid hydroperoxides (LPO) extraction from frozen rat tumors, intestine, liver, and heart tissuessues Bertin Technologies 51220](https://www.bertin-technologies.com/wp-content/uploads/2022/09/Group-faq.svg)
Context
The fundamental and clinical project of our research unit is positioned at the junction of the two fields “cancer and nutrition” with a specialization in lipid biochemistry and breast cancer. Our research unit has described the potential benefit of the clinical use of lipid nutrients in order to increase the efficiency of cancer treatment. Docosahexaenoic acid (DHA) has the potential to increase tumor sensitivity to chemotherapy with no sensitization of normal tissues. This study [1] was aimed at exploring the mechanism involved in this differential sensitization with a focus on oxidative stress, one of the main determinants involved in DHA enhancement of anthracycline-based chemotherapy.
